Dexcom Inc Stock Analysis

DexCom Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.14. DexCom Inc had not issued any dividends in recent years. The entity had 4:1 split on the 13th of June 2022. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California. Dexcom operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 6300 people. To learn more about DexCom Inc call Kevin Sayer at 858 200 0200 or check out https://www.dexcom.com.

DexCom Inc Investment Alerts

DexCom Inc Upcoming and Recent Events

DexCom Largest EPS Surprises

View All Earnings Estimates

DexCom Environmental, Social, and Governance (ESG) Scores

DexCom Thematic Classifications

DexCom Stock Institutional Investors

Note, although DexCom's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

DexCom Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 28.45 B.

DexCom Profitablity

The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.

Management Efficiency

DexCom Inc has return on total asset (ROA) of 0.0606 % which means that it generated a profit of $0.0606 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3206 %, meaning that it created $0.3206 on every $100 dollars invested by stockholders. DexCom's management efficiency ratios could be used to measure how well DexCom manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Tangible Assets is likely to grow to 0.09. Also, Return On Capital Employed is likely to grow to 0.13. At this time, DexCom's Net Tangible Assets are very stable compared to the past year. As of the 25th of November 2024, Intangible Assets is likely to grow to about 141.2 M, while Debt To Assets are likely to drop 0.37.

Technical Drivers

As of the 25th of November, DexCom shows the Coefficient Of Variation of 6494.34, mean deviation of 1.5, and Downside Deviation of 1.6. DexCom Inc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm DexCom Inc jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if DexCom Inc is priced favorably, providing market reflects its regular price of 72.83 per share. Given that DexCom has jensen alpha of 9.0E-4, we urge you to verify DexCom Inc's prevailing market performance to make sure the company can sustain itself at a future point.

DexCom Inc Price Movement Analysis

DexCom Inc Insider Trading Activities

DexCom Outstanding Bonds

DexCom Predictive Daily Indicators

DexCom Corporate Filings

DexCom Forecast Models

DexCom's time-series forecasting models are one of many DexCom's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DexCom's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how DexCom prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DexCom shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DexCom. By using and applying DexCom Stock analysis, traders can create a robust methodology for identifying DexCom entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. DexCom analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. DexCom analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

DexCom Inc stock analysis indicators help investors evaluate how DexCom stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading DexCom shares will generate the highest return on investment. By understating and applying DexCom stock analysis, traders can identify DexCom position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.